anonymous
Guest
anonymous
Guest
yea but monzon is still with you. He has all the answers.
Wait until the FDA orders them to stop selling on symptoms, but rather the indication they were studied and approved for ( Nasal Polyps). All smoke and mirrors.
Wait until the FDA orders them to stop selling on symptoms, but rather the indication they were studied and approved for ( Nasal Polyps). All smoke and mirrors.
i was a little confused. Kelly Bison kept walking in and out of interview rooms during interviews in Dallas.Didn’t say a word and when asked, she said she was VP of Sales. So where does that leave David Fabri? So much passive/ aggressive personalities and hung up in their titles. All they do is change messaging and specialty pharmacy and expect us to go back to customers and explain that it is really fixed this time ( 4 th go around). That is why so many reps left and Peter has nerve to say there are over 17 K scripts that were never adjudicated in 2018 by Foundation Care, but met with CEO and going with another specialty pharmacy? Really . Forget about ICD 10 codes for diagnosis for insurance Prior Auth, because then you would have to put something down that is related to Nasal Polyps diagnosis and not symptoms that may or may not include Polyps without scoping. That is why insurance companies don’t want PA to go through for chronic sinusitis and not Nasal Polyps, but just keep talking about symptoms and not indication. See how many of your docs snd billers ask you what codes to use if they are not diagnosed with Nasal Polyps. Just a matter of time before ENT’s complain they are pushing it for off label use. Come on doc, you scope don’t you? You don’t want to send out to ENT and lose that patient from a business standpoint, do you?
Sound familiar.. There is a difference between an ENT and Allergist for a reason...
Maybe they can answer FDA question why on 1 st CVA for Julia, it says right on front cover, “ she may of had Nasal Polyps in past.” Then she may have used Xhance in the past. They want us to sell on symptoms, not a diagnosed condition which is how Xhance received its approval ( on a diagnosed condition, period) in the first place . Not maybe congestion, reduction/ loss of smell taste, facial pain and runny nose.
Those are symptoms of rhinosinusitus ( with or without Polyps). We are indicated for the patients with the Polyps, not everyone like the company wants to infer. Leaving a study for a doctor to read that hasn’t been approved yet, ( wink wink) is as close as you can get to selling “ off label.”
I hope with all the calls they are going to get a cease and desist letter immediately goes out forthwith and quit pushing their reps to skirt the boundaries of “ off label” selling.
When Little Tommy said that doctors st Advisory Boards remembered the message about Nasal Polyps the most, well hello Mr. Mastermind, it is the first sentence of what we are indicated for and was primary endpoint in study for NDA.’
Hope they get hit with a hefty fine.
Oh yeah, the entire debacle re: specialty pharmacy is “ on me” guys. No kidding Sherlock.. Peter you need to surround yourself with some folks that know how to execute a sales strategy and by the way, get your lazy RBL’s to get back to their teams and not wait months for things promised and never deliver.
You lost the respect of those of us still around and the jungle line is alive and your deceit has done more harm to those of us still Here.
You have zero credibility and integrity must be a foreign language for you because EVERYONE heard the same messaging coming out of your mouth and your lackies too.
Good luck, because you have RBL’s who just left and we won’t be far behind.
You should be ashamed of yourself.
You mean the Advisiry Boards where Little Tommy said the majority of Doctors remember the sales message of Nasal Polyps, but not the symptoms. He had dinner with a Doc that after 20 minutes, finally said,” Now I get it.” So much for selling on indication and how many iof us have more than 5 minutes, even with a lunch, very few of top ENT’s even responded to their Advisory Boards ( aka trying to buy their business with an overwhelming presence of Upper Management, a stipend and dinner). They are about a decade behind the curve. Kelly is so condescending and corrects the RBL’s in front of their teams and thinks she has all the answers. What a B——.
Peter, wonder why some of us quit even though we were doing well. You need to look at who brings value to their teams and you have as RBL’s who are so passive- aggressive it is sickening. Self- promoting and have had 7 out of 10 reps leave, even though they were doing well. You even worked with one on a Thursday and rep gave notice Tuesday.
Some ( not all) do not support their teams ( no follow- up, wall flowers on sales calls, don’t know what they are talking about with MC and flat out lie when asked direct questions about direction from company).
You had good initial intentions but lost all credibility with Sales Team by flat out looking everyone in the face and lying. The undertone is you can never be trusted again regardless of the spin you and your henchmen try to put on at our upcoming meeting. You have done more to undermine your company than you realize. I will be out of here ASAP and many more too. The only one who has any credibility is Ramy and Harry Sacks.
Your “ Fearless Communication,” is just another tag line and like many others, including customers who say they will not write imperically , when a referral and definitive diagnosis can be confirmed,
You need to do some soul searching and wait until some of the FDA investigators start asking why you are encouraging us to promote symptoms and not diagnosed condition that we are indicated for.
More resignations to come.
You mean the Advisiry Boards where Little Tommy said the majority of Doctors remember the sales message of Nasal Polyps, but not the symptoms. He had dinner with a Doc that after 20 minutes, finally said,” Now I get it.” So much for selling on indication and how many iof us have more than 5 minutes, even with a lunch, very few of top ENT’s even responded to their Advisory Boards ( aka trying to buy their business with an overwhelming presence of Upper Management, a stipend and dinner). They are about a decade behind the curve. Kelly is so condescending and corrects the RBL’s in front of their teams and thinks she has all the answers. What a B——.
Peter, wonder why some of us quit even though we were doing well. You need to look at who brings value to their teams and you have as RBL’s who are so passive- aggressive it is sickening. Self- promoting and have had 7 out of 10 reps leave, even though they were doing well. You even worked with one on a Thursday and rep gave notice Tuesday.
Some ( not all) do not support their teams ( no follow- up, wall flowers on sales calls, don’t know what they are talking about with MC and flat out lie when asked direct questions about direction from company).
You had good initial intentions but lost all credibility with Sales Team by flat out looking everyone in the face and lying. The undertone is you can never be trusted again regardless of the spin you and your henchmen try to put on at our upcoming meeting. You have done more to undermine your company than you realize. I will be out of here ASAP and many more too. The only one who has any credibility is Ramy and Harry Sacks.
Your “ Fearless Communication,” is just another tag line and like many others, including customers who say they will not write imperically , when a referral and definitive diagnosis can be confirmed,
You need to do some soul searching and wait until some of the FDA investigators start asking why you are encouraging us to promote symptoms and not diagnosed condition that we are indicated for.
More resignations to come.